Background: Glioblastomas are the most common primary brain tumour in adults. While the prognosis for patients is poor, gene expression profiling has detected signatures that can sub-classify GBMs relative to histopathology and clinical variables. One category of GBM defined by a gene expression signature is termed ProNeural (PN), and has substantially longer patient survival relative to other gene expression-based subtypes of GBMs. Age of onset is a major predictor of the length of patient survival where younger patients survive longer than older patients. The reason for this survival advantage has not been clear.
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.
Sex, Age
View SamplesThis SuperSeries is composed of the SubSeries listed below.
Genomic landscape of meningiomas.
Sex, Age, Specimen part, Disease stage
View SamplesMeningiomas are one of the most common adult brain tumors. For most patients, surgical excision is curative. However, up to 20% recur. Currently, the molecular determinants predicting recurrence and malignant transformation are lacking. We performed global genetic and genomic analysis of 85 meningioma samples of various grades.
Genomic landscape of meningiomas.
Sex, Age, Specimen part, Disease stage
View Samples